HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 5.22
-0.04 (-0.76%)
Aug 22, 2025, 3:59 PM EDT
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 163.88 million as of August 22, 2025. Its market cap has increased by 65.21% in one year.
Market Cap
163.88M
Enterprise Value
223.09M
Revenue
76.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.22
Market Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 163.88M, a decrease of -48.45%. That is a compound annual growth rate of -8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 163.88M | 31.16% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | 571.39M | -27.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.98B |
| Green Thumb Industries | 2.68B |
| Trulieve Cannabis | 2.11B |
| Sienna Senior Living | 1.66B |
| dentalcorp Holdings | 1.63B |
| Cronos Group | 1.38B |
| WELL Health Technologies | 1.25B |
| Extendicare | 1.12B |